Ranbaxy Files Corrective Action Plan with FDA
Ranbaxy Files Corrective Action Plan. Generic drug maker Ranbaxy Laboratories LTD has filed a corrective action plan with the U.S. Food & Drug Administration (FDA). The FDA barred some of Ranbaxy's drugs from import to the U.S because of violations found during inspections of two plants in India. One of those plants was later … [Read more...] about Ranbaxy Files Corrective Action Plan with FDA
Ranbaxy Allegations Put FDA in Spotlight
Ranbaxy Allegations. Lawmakers probing allegations that generic drug maker Ranbaxy Laboratories Inc. imported defective drugs to the US have sent a letter to Food & Drug Administration (FDA) Commissioner Andrew von Eschenbach, demanding information on each drug Ranbaxy has approval to market here. Rep. John Dingell and Rep. … [Read more...] about Ranbaxy Allegations Put FDA in Spotlight
Congress to Probe FDA Handling of Ranbaxy
FDA Handling of Ranbaxy. Members of Congress are getting ready to investigate the scandal surrounding generic drug maker Ranbaxy. The House Energy and Commerce Committee has scheduled a hearing to probe the Food and Drug Administration's (FDA) handling of allegations Ranbaxy sold potentially adulterated medicines. Based … [Read more...] about Congress to Probe FDA Handling of Ranbaxy
Ranbaxy Investigation Heating Up
Ranbaxy Investigation. US prosecutors have alleged that generic drug maker Ranbaxy forged documents relating to an investigation into the quality of the company's drugs sold in the this country. The allegations were revealed in a motion the Justice Department filed this month in federal court in Maryland. The motion is part of a … [Read more...] about Ranbaxy Investigation Heating Up
